 |
|
|
| |
Efficacy of Boceprevir in Prior Null Responders to Peginterferon/Ribavirin: The PROVIDE Study
|
| |
| |
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
J. Vierling1, S. Flamm2, S. Gordon3, E. Lawitz4, J-P. Bronowicki5, M. Davis6, E. Yoshida7, L.D. Pedicone8, W. Deng8, M. Treitel8, C. Brass8, J. Albrecht8, and I. Jacobson9
1Baylor College of Medicine, Houston, TX; 2Northwestern Feinberg School of Medicine, Chicago, IL; 3Henry Ford Hospital, Detroit, MI; 4Alamo Medical Research, San Antonio, TX; 5University Henri Poincare of Nancy, Vandoeuvre-les-Nancy, France; 6South Florida Center of Gastroenterology, Wellington, FL; 7University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada; 8Merck Sharp & Dohme Corp., Whitehouse Station, NJ; 9Weill Cornell Medical College, New York, NY
|
| |
|
|
|
|
|
